Latest Institutional Purchases of Oric Pharmaceuticals, Inc. (ORIC)
This list provides information on the latest institutional transactions involving Oric Pharmaceuticals, Inc. (ORIC) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
9K+ 80.19% |
$38.4K - $60.8K
|
20.2K
$155K
|
|
May 15, 2023
Q1 2023
|
Point72 Middle East Fze
Stamford, CT |
BUY
|
- |
5.71KNew |
$24.3K - $38.6K
|
5.71K
$43.9K
|
|
May 15, 2023
Q1 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
BUY
|
- |
836+ 15.27% |
$3.56K - $5.64K
|
6.31K
$48.5K
|
|
Q4 2022 | |||||||
Feb 01, 2023
Q4 2022
|
Bank Of Montreal
Toronto, A6 |
BUY
|
- |
108KNew |
$260K - $634K
|
108K
$827K
|
|
Feb 14, 2023
Q4 2022
|
683 Capital Management, LLC
New York, NY |
BUY
|
- |
33.8KNew |
$81.5K - $199K
|
33.8K
$260K
|
|
Feb 14, 2023
Q4 2022
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
13.3KNew |
$32.1K - $78.4K
|
13.3K
$102K
|
|
Feb 14, 2023
Q4 2022
|
Pensionmark Financial Group, LLC
Santa Barbara, CA |
BUY
|
- |
10.7KNew |
$25.8K - $63K
|
10.7K
$82.2K
|
|
Feb 14, 2023
Q4 2022
|
Prelude Capital Management, LLC
New York, NY |
BUY
|
- |
143+ 0.94% |
$345 - $842
|
15.4K
$118K
|
|
Q3 2022 | |||||||
Nov 14, 2022
Q3 2022
|
Apogem Capital LLC
New York, NY |
BUY
|
- |
65.8KNew |
$207K - $345K
|
65.8K
$505K
|
|
Oct 18, 2022
Q3 2022
|
Bailard, Inc.
|
BUY
|
- |
38.5KNew |
$121K - $202K
|
38.5K
$296K
|
|
Nov 15, 2022
Q3 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
BUY
|
- |
24.1KNew |
$76K - $126K
|
24.1K
$185K
|
|
Nov 14, 2022
Q3 2022
|
Point72 Hong Kong LTD
Hong Kong, K3 |
BUY
|
- |
1.32K+ 1201.82% |
$4.16K - $6.93K
|
1.43K
$11K
|
|
Nov 09, 2022
Q3 2022
|
Capital Advisors, Ltd. LLC
|
BUY
|
- |
9+ 5.73% |
$28.3 - $47.2
|
166
$1.27K
|
|
Q2 2022 | |||||||
Aug 15, 2022
Q2 2022
|
Oasis Management CO Ltd.
Grand Cayman, E9 |
BUY
|
- |
272KNew |
$736K - $1.93M
|
272K
$2.09M
|
|
Aug 15, 2022
Q2 2022
|
Sei Investments CO
Oaks, PA |
BUY
|
- |
15.1KNew |
$40.6K - $106K
|
15.1K
$116K
|
|
Aug 15, 2022
Q2 2022
|
Laurion Capital Management LP
New York, NY |
BUY
|
- |
11.9KNew |
$32.2K - $84.4K
|
11.9K
$91.7K
|
|
Aug 08, 2022
Q2 2022
|
Y Intercept (Hong Kong) LTD
|
BUY
|
- |
10.8KNew |
$29.2K - $76.6K
|
10.8K
$83.2K
|
|
Aug 11, 2022
Q2 2022
|
Beacon Pointe Advisors, LLC
Newport Beach, CA |
BUY
|
- |
10KNew |
$27.1K - $71K
|
10K
$77.1K
|
|
Jul 18, 2022
Q2 2022
|
Ellevest, Inc.
|
BUY
|
- |
143+ 1100.0% |
$386 - $1.01K
|
156
$1.2K
|
|
Q1 2022 | |||||||
May 16, 2022
Q1 2022
|
Captrust Financial Advisors
Raleigh, NC |
BUY
|
- |
1.88KNew |
$8.55K - $30.3K
|
1.88K
$14.5K
|
|
Q4 2021 | |||||||
Feb 11, 2022
Q4 2021
|
Jasper Ridge Partners, L.P.
Menlo Park, CA |
BUY
|
- |
20.9KNew |
$251K - $424K
|
20.9K
$160K
|
|
Feb 11, 2022
Q4 2021
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
BUY
|
- |
10.4KNew |
$124K - $210K
|
10.4K
$79.6K
|
|
Q3 2021 | |||||||
Oct 19, 2021
Q3 2021
|
Janiczek Wealth Management, LLC
|
BUY
|
- |
9.12KNew |
$145K - $230K
|
9.12K
$70K
|
|
Q2 2021 | |||||||
Aug 13, 2021
Q2 2021
|
Artal Group S.A.
Luxembourg, N4 |
BUY
|
- |
300K+ 300.0% |
$5.21M - $7.6M
|
400K
$3.07M
|
|
Q1 2021 | |||||||
May 14, 2021
Q1 2021
|
Credit Suisse Ag
Zurich, V8 |
BUY
|
CALL |
11.3KNew |
$267K - $416K
|
11.3K
$86.8K
|
|
May 12, 2021
Q1 2021
|
E Fund Management Co., Ltd.
Guangzhou, F4 |
BUY
|
- |
2.8KNew |
$66.3K - $103K
|
2.8K
$21.5K
|
|
Q4 2020 | |||||||
Feb 16, 2021
Q4 2020
|
Memorial Sloan Kettering Cancer Center
New York, NY |
BUY
|
- |
602KNew |
$12.2M - $24M
|
602K
$4.63M
|
|
Feb 16, 2021
Q4 2020
|
Casdin Capital, LLC
New York, NY |
BUY
|
- |
350K+ 139.16% |
$7.11M - $13.9M
|
602K
$4.62M
|